- Home
- GSBC vs TRVI Comparison
GSBC vs TRVI Comparison
Compare GSBC & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSBC
- TRVI
- Stock Information
- Founded
- GSBC 1923
- TRVI 2011
- Country
- GSBC United States
- TRVI United States
- Employees
- GSBC N/A
- TRVI N/A
- Industry
- GSBC Major Banks
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- GSBC Finance
- TRVI Health Care
- Exchange
- GSBC Nasdaq
- TRVI Nasdaq
- Market Cap
- GSBC 665.7M
- TRVI 725.7M
- IPO Year
- GSBC N/A
- TRVI 2019
- Fundamental
- Price
- GSBC $59.02
- TRVI $6.89
- Analyst Decision
- GSBC Hold
- TRVI Strong Buy
- Analyst Count
- GSBC 2
- TRVI 9
- Target Price
- GSBC $59.50
- TRVI $19.94
- AVG Volume (30 Days)
- GSBC 95.4K
- TRVI 1.6M
- Earning Date
- GSBC 07-16-2025
- TRVI 08-07-2025
- Dividend Yield
- GSBC 2.70%
- TRVI N/A
- EPS Growth
- GSBC 10.52
- TRVI N/A
- EPS
- GSBC 5.60
- TRVI N/A
- Revenue
- GSBC $219,572,000.00
- TRVI N/A
- Revenue This Year
- GSBC N/A
- TRVI N/A
- Revenue Next Year
- GSBC $1.04
- TRVI N/A
- P/E Ratio
- GSBC $10.57
- TRVI N/A
- Revenue Growth
- GSBC N/A
- TRVI N/A
- 52 Week Low
- GSBC $47.58
- TRVI $2.36
- 52 Week High
- GSBC $68.02
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- GSBC 48.83
- TRVI 64.54
- Support Level
- GSBC $60.21
- TRVI $5.41
- Resistance Level
- GSBC $62.90
- TRVI $6.08
- Average True Range (ATR)
- GSBC 1.45
- TRVI 0.32
- MACD
- GSBC -0.08
- TRVI 0.14
- Stochastic Oscillator
- GSBC 25.38
- TRVI 89.91
About GSBC Great Southern Bancorp Inc.
Great Southern Bancorp Inc is a bank holding company. It is principally engaged in the business of originating residential and commercial real estate loans, construction loans, commercial business loans, and consumer loans. The bank provides various services such as Business Banking, Merchant Services, Debit and Credit cards, Online Banking, Mobile Banking, VIP Banking, Overdraft Protection, and various other related services. It operates into a single segment which is Community Banking.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.